Shimizu Y

No ORCID on file · 27 papers in corpus · active 1983-2023

Study types

  • other 10
  • article 9
  • case-report 2
  • review 2

Condition tags

  • endometriosis 19
  • adenomyosis 2
  • dysmenorrhea 1
  • infertility 1
  • endometrioma 1
2023
BMJ case reports ·doi:10.1136/bcr-2022-254262

Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome, a condition caused by Müllerian anomalies, is characterised by congenital vaginal aplasia and a rudimentary uterus. Case reports concerning uterine fibroids associated with MRKH syndrome are l…

review 2022
Advances in therapy ·doi:10.1007/s12325-022-02298-9

INTRODUCTION: Although several studies suggest beneficial effects of low-dose estrogen-progestins (LEPs) and progestins on dysmenorrhea in Japanese women, the difference in efficacy between drugs remains unknown. METHODS: We identified stud…

other 2017
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2017.04.048

OBJECTIVE: C-C motif chemokine ligand 20 is thought to contribute to the development of endometriosis by recruiting Th17 lymphocytes into endometriotic foci. The present study investigated the effects of dienogest, a progesterone receptor a…

article 2014
The Journal of steroid biochemistry and molecular biology ·doi:10.1016/j.jsbmb.2014.12.008

Dienogest (DNG) is a selective progesterone receptor (PR) agonist and oral administration of DNG is used for the treatment of endometriosis. DNG is considered to act on PR to down-regulate pathophysiological factors associated with endometr…

article 2014
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2014.03.019

ObjectiveTo determine the immunological effect of dienogest (DNG), an oral anti-endometriosis drug, on peritoneal fluid (PF) macrophages collected from women with endometriosis. Although it has been suggested that DNG has direct effects on …

other 2014
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2014.05.031

OBJECTIVES: To investigate the direct effects of progesterone receptor (PR) agonists on proliferation and apoptosis of human adenomyotic cells. STUDY DESIGN: Human primary cultures of adenomyotic stromal cells (ASCs) from 24 patients with …

article 2013
Fertility and sterility ·doi:10.1016/j.fertnstert.2013.10.038

ObjectiveDienogest (DNG), a selective P receptor (PR) agonist, is used to treat endometriosis. To investigate whether DNG affects nerve growth factor (NGF) expression, we stimulated human endometrial epithelial cells (hEECs) with inflammato…

2013
Journal of lipid research ·doi:10.1194/jlr.m042473

Apolipoprotein E (apoE) is the major lipid carrier in the central nervous system. As apoE plays a major role in the pathogenesis of Alzheimer disease (AD) and also mediates repair pathways after several forms of acute brain injury, modulati…

2013
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-013-9991-3

PurposeAlthough studies of serum anti-Müllerian hormone (AMH) in predicting ovarian reserve are numerous, many studies utilized patients under age 40. However, the assessment of ovarian reserve is especially critical in older infertile wome…

article 2012
Fertility and sterility ·doi:10.1016/j.fertnstert.2011.11.005

ObjectiveTo determine the effect of dienogest (DNG) on the expression of aromatase and cyclooxygenase-2 (COX-2) and the production of prostaglandin E(2) (PGE(2)) in human endometriotic stromal cells (ESCs).DesignExperimental study in vitro.…

article 2010
Steroids ·doi:10.1016/j.steroids.2010.08.010

Prostaglandin E(2) (PGE(2)) is a major mediator in the pathophysiology, and pathogenesis of gynecological diseases associated with abnormal endometrial disease with proliferation and inflammation, such as endometriosis. In this study, we in…

article 2010
Human Reproduction ·doi:10.1093/humrep/deq241

BACKGROUND: We aimed to establish an endometrial autograft model in rats that would allow for repetitive in vivo analyses of angiogenesis. Dienogest (DNG) is an orally active progestin used for the treatment of endometriosis. We investigate…

other 2010
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/j.1447-0756.2009.01119.x

AIM: To retrospectively assess the long-term outcome, including pregnancy rate, recurrence rate and ovarian reserve, after laser ablation surgery in infertile women with endometrioma. METHODS: From March 1997 to June 2007, 45 subfertile wo…

article 2009
Molecular human reproduction ·doi:10.1093/molehr/gap042

Dienogest is a specific progesterone receptor agonist with potent oral endometrial activity and is used in the treatment of endometriosis. In this study, we examined the direct effects of dienogest on the proliferation of human endometrial …

review 2009
Nihon yakurigaku zasshi. Folia pharmacologica Japonica ·doi:10.1254/fpj.133.32

ジエノゲスト(販売名:ディナゲスト錠1 mg)は,プロゲステロン受容体に対して選択的なアゴニスト活性を示す第4世代のプロゲスチンである.ジエノゲストは,ラットおよびウサギに経口投与することによりプロゲステロン作用を示し,一方,アンドロゲン作用,グルココルチコイド作用およびミネラルコルチコイド作用は示さなかった.ジエノゲストは,カニクイザルに反復経口投与することにより月経周期の停止,月経周期に伴う血中エストラジオール濃度の上昇および黄体形成ホルモン濃度の上昇を抑制し,卵巣機能抑…

case-report 2004
Reproductive medicine and biology ·doi:10.1111/j.1447-0578.2004.00057.x

Three women with adenomyosis conceived by in vitro fertilization-embryo transfer (IVF-ET), but miscarried in the second trimester. The uterus in each case was inflamed post-partum and one patient underwent total abdominal hysterectomy as tr…

other 2001
Gynecologic oncology ·doi:10.1006/gyno.2001.6322

OBJECTIVE: Steroid sulfatase (STS) is an important enzyme that converts biological inactive steroid sulfate to active free steroid. As estrogen is thought to play an important role in cell proliferation in gynecological cancer, the existenc…

other 1999
Fertility and Sterility ·doi:10.1016/s0015-0282(98)00417-8

OBJECTIVE: To investigate the incidence of spontaneous conception after the birth of infants conceived through IVF in couples with subfertility caused by endometriosis, a mild male factor, or unexplained factors, and to identify clinical co…

1999
Proceedings of the National Academy of Sciences of the United States of America ·doi:10.1073/pnas.96.21.12027

The biological roles of estrogen-responsive finger protein (efp) in vivo were evaluated in mice carrying a loss-of-function mutation in efp by gene-targeted mutagenesis. Although efp homozygous mice were viable and fertile in both sexes, th…

article 1996
Fertility and Sterility ·doi:10.1016/s0015-0282(16)58692-0

ObjectiveTo evaluate the effectiveness of IVF treatment in endometriosis-associated infertility.DesignNonrandom retrospective study.SettingDepartment of Gynecology and Obstetrics, Akita University School of Medicine.Main outcome measure(s)C…

other 1995
Steroids ·doi:10.1016/0039-128x(94)00043-c

Mifepristone (RU 486), used clinically for the termination of early pregnancy, and its acetyl and 13-retro (13 alpha) analogs show potent antiproliferative effects against estrogen-dependent human breast tumors and endometriosis. However, t…

other 1990
Nihon Sanka Fujinka Gakkai zasshi

Immunohistochemical study with various monoclonal antibodies to the mononuclear cell surface antigens was carried out on the regional lymph nodes in patients with cervical cancer to assess the augmentative effect of lentinan. Zero, 2, 4, or…

other 1989
Nihon Sanka Fujinka Gakkai zasshi

The clinical and pathological findings in 23 cases of clear cell carcinoma of the ovary treated at Cancer Institute Hospital from January 1951 to September 1987 are discussed. Clear cell carcinoma accounted for 7.1% of all malignant tumors …

case-report 1989
Gynecologic oncology ·doi:10.1016/0090-8258(89)90558-1

With an enzymatic technique, serum sialic acid (SA) levels were determined in patients with gynecologic tumors. Since the SA level for healthy females was 57.4 +/- 7.3 mg/dl, we set the upper normal limit of this parameter at 72 mg/dl. The …

other 1986
Gan to kagaku ryoho. Cancer & chemotherapy

CA 125 antigen levels were measured in patients with ovarian cancer (54 cases) by the RIA method using a monoclonal antibody OC 125 and were examined as a marker for ovarian cancer. The upper normal limit of CA 125 of 35 U/ml was derived fr…